Avy Violari

6.8k citations

122 papers · 4.1k indexed · 2 hit papers · h-index 30

Impact in

Virology top 0.5%
- HIV Research and Treatment
Infectious Diseases top 0.5%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment

Papers in ⓘ

Virology 37
- HIV Research and Treatment 37
Infectious Diseases 92
- HIV/AIDS Research and Interventions 81
- HIV/AIDS drug development and treatment 24

Co-authors: Shabir A. Madhi (31 shared papers)Patrick Jean‐Philippe (15 shared papers)James McIntyre (14 shared papers)Diana M. Gibb (13 shared papers)Mark F. Cotton (4 shared papers)Abdel G. Babiker (2 shared papers)Jan Steyn (1 shared paper)Mark F. Cotton (41 shared papers)
Journals: JAIDS Journal of Acquired Immune Deficiency Syndromes (12 papers)AIDS (10 papers)PLoS ONE (10 papers)AIDS Care (7 papers)The International Journal of Tuberculosis and Lung Disease (6 papers)
Partner nations: South Africa United States United Kingdom

In The Last Decade

Avy Violari

116 papers receiving 4.0k citations

Hit Papers

align trajectories log scale

Influenza Vaccination of Pregnant Women and Protection of Their Infants 2014 · 389 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 New England Journal of Medicine
2008 New England Journal of Medicine

Peers

Countries citing papers authored by Avy Violari

Since Specialization

Citations

This map shows the geographic impact of Avy Violari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avy Violari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avy Violari more than expected).

Fields of papers citing papers by Avy Violari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avy Violari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avy Violari. The network helps show where Avy Violari may publish in the future.

Co-authors

The 25 scholars most cited alongside Avy Violari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Avy Violari Line = papers co-authored together Avy Violari links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 122 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Early Antiretroviral Therapy and Mortality among HIV-Infected Infants New England Journal of Medicine ·Avy Violari, Mark F. Cotton, Diana M. Gibb, Abdel G. Babiker, Jan Steyn, Shabir A. Madhi, Patrick Jean‐Philippe, James McIntyre Hit paper breakdown →	2008	1037
2	Influenza Vaccination of Pregnant Women and Protection of Their Infants New England Journal of Medicine ·Shabir A. Madhi, Clare Cutland, Locadiah Kuwanda, Adriana Weinberg, Andrea Hugo, Stephanie Jones, Peter V. Adrian, Nadia van Niekerk, Florette K. Treurnicht, Justin R. Ortiz, Marietjie Venter, Avy Violari, Kathleen M. Neuzil, Eric A. F. Simões, Keith P. Klugman, Marta C. Nunes Hit paper breakdown →	2014	389
3	Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial The Lancet ·Mark F. Cotton, Avy Violari, Kennedy Otwombe, Ravindre Panchia, Els Dobbels, Helena Rabie, Deirdre Josipovic, Afaaf Liberty, Erica Lazarus, Steve Innes, Anita Janse van Rensburg, Wilma Pelser, Handré Truter, Shabir A. Madhi, Edward Handelsman, Patrick Jean‐Philippe, James McIntyre, Diana M. Gibb, Abdel G. Babiker	2013	181
4	Antiretroviral Treatment for Children with Peripartum Nevirapine Exposure New England Journal of Medicine ·Paul Palumbo, Jane C. Lindsey, Michael D. Hughes, Mark F. Cotton, Raziya Bobat, Tammy Meyers, Mutsa Bwakura‐Dangarembizi, H. Benjamin, Philippa Musoke, Portia Kamthunzi, Werner Schimana, Lynette Purdue, Susan H. Eshleman, Elaine J. Abrams, Linda Millar, Elizabeth Petzold, Lynne Mofenson, Patrick Jean‐Philippe, Avy Violari	2010	172
5	Nevirapine versus Ritonavir-Boosted Lopinavir for HIV-Infected Children New England Journal of Medicine ·Avy Violari, Jane C. Lindsey, Michael D. Hughes, Hilda Mujuru, Linda Barlow‐Mosha, Portia Kamthunzi, H. Benjamin, Mark F. Cotton, Harry Moultrie, Sandhya Khadse, Werner Schimana, Raziya Bobat, Lynette Purdue, Susan H. Eshleman, Elaine J. Abrams, Linda Millar, Elizabeth Petzold, Lynne Mofenson, Patrick Jean‐Philippe, Paul Palumbo	2012	150
6	Early antiretroviral therapy improves neurodevelopmental outcomes in infants AIDS ·Barbara Laughton, Morna Cornell, D Grové, Martin Kidd, Priscilla Springer, Els Dobbels, Anita Janse van Rensburg, Avy Violari, Abdel G. Babiker, Shabir A. Madhi, Patrick Jean‐Philippe, Diana M. Gibb, Mark F. Cotton	2012	135
7	Correction: Association of pol Diversity with Antiretroviral Treatment Outcomes among HIV-Infected African Children PLoS ONE ·I‐Ming Chen, Pejvak Khaki, Jane C. Lindsey, Carrie Fry, Matthew M. Cousins, Robert F. Siliciano, Avy Violari, Paul Palumbo, Susan H. Eshleman	2013	133
8	Influenza Vaccination of Pregnant Women and Protection of Their Infants Obstetrical & Gynecological Survey ·Shabir A. Madhi, Clare Cutland, Locadiah Kuwanda, Adriana Weinberg, Andrea Hugo, Stephanie Jones, Peter V. Adrian, Nadia van Niekerk, Florette K. Treurnicht, Justin R. Ortiz, Marietjie Venter, Avy Violari, Kathleen M. Neuzil, Eric A. F. Simões, Keith P. Klugman, Marta C. Nunes	2015	125
9	Primary Isoniazid Prophylaxis against Tuberculosis in HIV-Exposed Children New England Journal of Medicine ·Shabir A. Madhi, Sharon Nachman, Avy Violari, Soyeon Kim, Mark F. Cotton, Raziya Bobat, Patrick Jean‐Philippe, George McSherry, Charles D. Mitchell	2011	118
10	The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life BMC Medicine ·Vivek Naranbhai, Soyeon Kim, Helen A. Fletcher, Mark F. Cotton, Avy Violari, Charles D. Mitchell, Sharon Nachman, George McSherry, Helen McShane, Adrian V. S. Hill, Shabir A. Madhi	2014	74
11	A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers AIDS ·Glenda Gray, Michael Urban, Matthew Chersich, Carolyn Bolton‐Moore, Ronelle van Niekerk, Avy Violari, Wendy Stevens, James McIntyre	2005	64
12	Early severe HIV disease precedes early antiretroviral therapy in infants: Are we too late? Journal of the International AIDS Society ·Steve Innes, Erica Lazarus, Kennedy Otwombe, Afaaf Liberty, Ramona Germanus, Anita Janse van Rensburg, Nelis Grobbelaar, Theunis Hurter, Brian Eley, Avy Violari, Mark F. Cotton	2014	63
13	Active Tuberculosis Case-Finding Among Pregnant Women Presenting to Antenatal Clinics in Soweto, South Africa JAIDS Journal of Acquired Immune Deficiency Syndromes ·Céline R. Gounder, Nikolas Wada, Caroline Kensler, Avy Violari, James McIntyre, Richard E. Chaisson, Neil Martinson	2011	60
14	Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial AIDS ·Michael J. Boivin, Linda Barlow‐Mosha, Miriam C. Chernoff, Barbara Laughton, Bonnie Zimmer, Celeste Joyce, Mutsa Bwakura‐Dangarembizi, Mmule Ratswana, Nasreen Abrahams, Lee Fairlie, Hermien Gous, Portia Kamthunzi, Katie McCarthy, Itziar Familiar‐Lopez, Patrick Jean–Phillippe, Joan Coetzee, Avy Violari, Mark C. Cotton, Paul Palumbo	2017	54
15	A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation Nature Communications ·Avy Violari, Mark F. Cotton, Louise Kuhn, Diana B. Schramm, Maria Paximadis, Shayne Loubser, Sharon Shalekoff, Bianca Da Costa Dias, Kennedy Otwombe, Afaaf Liberty, James McIntyre, Abdel Babiker, Diana M. Gibb, Caroline T. Tiemessen	2019	53
16	Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy AIDS ·Omphile E. Simani, Alane Izu, Avy Violari, Mark F. Cotton, Nadia van Niekerk, Peter V. Adrian, Shabir A. Madhi	2014	50
17	HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort. PubMed ·Neil Martinson, Harry Moultrie, Ronelle van Niekerk, Gillian Barry, Ashraf Coovadia, Mark F. Cotton, Avy Violari, Glenda Gray, Richard E. Chaisson, James McIntyre, T. Meyers	2009	49
18	Combining PMTCT With Active Case Finding for Tuberculosis JAIDS Journal of Acquired Immune Deficiency Syndromes ·Paula B.N. Kali, Glenda Gray, Avy Violari, Richard E. Chaisson, James McIntyre, Neil Martinson	2006	48
19	Gamma Interferon Production in Response toMycobacterium bovisBCG andMycobacterium tuberculosisAntigens in Infants Born to Human Immunodeficiency Virus-Infected Mothers Clinical and Vaccine Immunology ·Annelies Van Rie, Shabir A. Madhi, Jayvant Heera, Stephen Meddows‐Taylor, Aaron M. Wendelboe, Fiona Anthony, Avy Violari, Caroline T. Tiemessen	2006	46
20	Genotypic and Phenotypic Characterization of Viral Isolates from HIV-1 Subtype C-Infected Children with Slow and Rapid Disease Progression AIDS Research and Human Retroviruses ·Isaac Choge, Tonie Cilliers, Polly Walker, Natasha Taylor, Mary Phoswa, Tammy Meyers, Johannes Viljoen, Avy Violari, Glenda Gray, Penny L. Moore, Maria Papathanosopoulos, Lynn Morris	2006	45

About Avy Violari

Avy Violari is a scholar working on Virology, Infectious Diseases, Emergency Medicine, Safety Research and Epidemiology, having authored 122 papers that have together received 4.1k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (81 papers), HIV Research and Treatment (37 papers), Adolescent Sexual and Reproductive Health (25 papers), HIV/AIDS drug development and treatment (24 papers), HIV-related health complications and treatments (22 papers), Pneumocystis jirovecii pneumonia detection and treatment (13 papers), Pneumonia and Respiratory Infections (11 papers) and Poverty, Education, and Child Welfare (10 papers). The work is most often cited by research in Virology (1.4k citations), Infectious Diseases (2.8k citations), Emergency Medicine (660 citations), Epidemiology (1.6k citations) and Health (321 citations). Avy Violari has collaborated with scholars based in South Africa, United States and United Kingdom. Frequent co-authors include Shabir A. Madhi, Patrick Jean‐Philippe, James McIntyre, Diana M. Gibb, Mark F. Cotton, Abdel G. Babiker, Jan Steyn, Mark F. Cotton, Peter V. Adrian and Rachel Kidman. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, AIDS, PLoS ONE, AIDS Care and The International Journal of Tuberculosis and Lung Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact